You are here
- Home
- Therapy Areas
- Cardiovascular
A phase I, open-label, pharmacokinetic study measuring plasma exposure of a 20 mg single dose administration of rosuvastatin calcium to healthy Asian subjects living in the United States related to the pharmacokinetic data obtained from a Caucasian control group
- Disease
- hypercholesterolaemia, diabetes type 2, dyslipidaemia
- Drug Name
- Crestor
- Generic Name
- rosuvastatin
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- Other
- Start Date
- Jan 18, 1971
- Study Name
- D3560C00001
- Study Id
- D3560C00001
- ClinicalTrials.gov ID
- Not Applicable
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
